Reasons for Switching to Fingolimod in Patients Relapsing-Remitting Multiple Sclerosis in France: the ESGILE Study.
Ayman Tourbah,Caroline Papeix,Patricia Tourniaire,Karin Rerat,Mohamed Meite,Barbara Durand,Fabienne Lamy,Isabelle Chouette,Claude Mekies, Jennyfer Aboab,Abdullatif Al Khedr, Amer Al Najjar Carpentier,Geraldine Androdias,Rabah Benrabah,Damien Biotti, Valentin Bohotin,Mickael Bonnan, Cecilia Bonnet, Jean Marc Boulesteix,David Brassat, Philippe Busson,William Camu,Giovanni Castelnovo, Stephane Chapuis,Pierre Clavelou,Philippe Convers,Marc Coustans,Alain Creange, Sebastien Delassaux,Eric Diot, Madjid Djerdi, Thomas Drouet, Sophie Dufour Delalande, Corinne Dupel Pottier,Didier Ferriby, Philippe Gaida,Guillaume Gal,Pierric Giraud,Laurent Guilloton, Tijani Hascar,Olivier Heinzlef, Violaine Jaffrenou Rouaud,Alain Jager, Christophe Kubler,Patrick Le Coz,Christine Lebrun Frenay,Elisabeth Maillart, Paris Marcel Maillet Vioud, Imad Malkoun,Eric Manchon,Mikel Martinez, Dalia Meshaka Dimitri Boulos,Alexis Montcuquet,Thibault Moreau,Antoine Moulignier,Jean-Philippe Neau, Philippe Neuschwander, Ghislain Nokam Talom,Jean-Christophe Ouallet,Ivania Patry,Stephane Peysson, Nathalie Rosey Dufosse, Feras Abdul Samad, Nicolas Schmidt, Nicolas Seiller, Thierry Soisson,Eric Thouvenot,Mathieu Vaillant, Anne-Evelyne Vallet Racinoux,Nadia Vandenberghe,Frederique Viala, Valery Wattier,Christophe Zaenker,Fabien Zagnoli, Hatem Zekri Multiple Sclerosis and Related Disorders（2020）
关键词
multiple sclerosis,fingolimod,switching,treatment acceptability,patient-reported outcome
AI 理解论文
溯源树
样例
